GLP-1 agonists work by mimicking the action of naturally occurring GLP-1, an incretin hormone released by the intestine in response to food intake
"Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review"
Decyzja o wyborze preparatu powinna zosta skonsultowana z lekarzem, ktry powinien dobra lek jak najlepiej dopasowany do potrzeb pacjenta
Postmarketing surveillance and observational studies have reported cases of pancreatitis in patients receiving GLP-1 receptor agonists, although a causal relationship remains debated and confounded by underlying disease risk factors ( In addition, rodent studies demonstrating thyroid C-cell hyperplasia and tumors led to class warnings and contraindications in susceptible populations
In this review, we will describe the positive outcomes of GLP-1RAs on cardiovascular disease with a specific focus on outcomes related to metabolic and lipid profiles
This can indicate blood sugar dysregulation, excessive GH affecting sleep architecture, or simply too many compounds stressing your system